Cognitive and Speech Disorders in 5-7 Years Old Children With Congenital Heart Defects

Kemerovo State Medical University1 site in 1 country217 target enrollmentMarch 1, 2019

ConditionsCognition Disorder

Overview

Phase: N/A
Intervention: Not specified
Conditions: Cognition Disorder
Sponsor: Kemerovo State Medical University
Enrollment: 217
Locations: 1
Primary Endpoint: Neurocognitive status
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The study is aimed to found out expressive speech disorders as a sign of neurocognitive development delay in children with congenital heart defects before and after surgery

Detailed Description

The study will investigate the influence of congenital heart disease, operation and other health factors on neurocognitive and speech status of 5-7 years old children

Registry

clinicaltrials.gov

Start Date

March 1, 2019

End Date

August 1, 2024

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Kemerovo State Medical University

Responsible Party

Principal Investigator

Evgeny Grigoryev

Head of the Department of Anesthesiology

Kemerovo State Medical University

Eligibility Criteria

Inclusion Criteria

•children with congenital heart disease that required total correction using cardiopulmonary bypass

Exclusion Criteria

•patients with heart disease requiring palliative or endovascular correction, as well as children with chromosomal and genetic diseases (determined by karyotyping)

Outcomes

Primary Outcomes

Neurocognitive status

Time Frame: 2 years

Monitoring before the cardiovascular operation and in postoperative period (in 1 and 2 years). Assessment of speech disorders, short-term and long-term memory impairments.